{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T04:24:10Z","timestamp":1795148650614,"version":"4.10.3"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["CYB23199"],"award-info":[{"award-number":["CYB23199"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82302164"],"award-info":[{"award-number":["No. 82302164"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82102063"],"award-info":[{"award-number":["No. 82102063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82271970"],"award-info":[{"award-number":["No. 82271970"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2021jcyj -msxmX0040"],"award-info":[{"award-number":["cstc2021jcyj -msxmX0040"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-02939-x","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T08:40:29Z","timestamp":1730104829000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Macrophage membrane-functionalized manganese dioxide nanomedicine for synergistic treatment of atherosclerosis by mitigating inflammatory storms and promoting cholesterol efflux"],"prefix":"10.1186","volume":"22","author":[{"given":"Sijin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiyue","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongsheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,28]]},"reference":[{"key":"2939_CR1","doi-asserted-by":"publisher","first-page":"108172","DOI":"10.1016\/j.pharmthera.2022.108172","volume":"237","author":"MJ Chapman","year":"2022","unstructured":"Chapman MJ, Zamorano JL, Parhofer KG. Reducing residual cardiovascular risk in Europe: therapeutic implications of European medicines agency approval of icosapent ethyl\/eicosapentaenoic acid. Pharmacol Ther. 2022;237:108172.","journal-title":"Pharmacol Ther"},{"key":"2939_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jaccao.2021.02.006","volume":"3","author":"J Valero-Elizondo","year":"2021","unstructured":"Valero-Elizondo J, Chouairi F, Khera R, Grandhi GR, Saxena A, Warraich HJ, Virani SS, Desai NR, Sasangohar F, Krumholz HM, et al. Atherosclerotic Cardiovascular Disease, Cancer, and financial toxicity among adults in the United States. JACC CardioOncol. 2021;3:236\u201346.","journal-title":"JACC CardioOncol"},{"key":"2939_CR3","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592:524\u201333.","journal-title":"Nature"},{"key":"2939_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/CIRCRESAHA.115.307611","volume":"118","author":"W Herrington","year":"2016","unstructured":"Herrington W, Lacey B, Sherliker P, Armitage J, Lewington S. Epidemiology of atherosclerosis and the potential to reduce the global burden of Atherothrombotic Disease. Circ Res. 2016;118:535\u201346.","journal-title":"Circ Res"},{"key":"2939_CR5","doi-asserted-by":"publisher","first-page":"100064","DOI":"10.59717\/j.xinn-med.2024.100064","volume":"2","author":"M Zheng","year":"2024","unstructured":"Zheng M, Wang X, Yin Y, Chen S, Guo C, Wu S, Yuan Y. New-onset age of metabolic-associated fatty liver disease and incident cardiovascular diseases: findings from prospective cohort. Innov Med. 2024;2:100064.","journal-title":"Innov Med"},{"key":"2939_CR6","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1474-4422(19)30035-3","volume":"18","author":"L Saba","year":"2019","unstructured":"Saba L, Saam T, J\u00e4ger HR, Yuan C, Hatsukami TS, Saloner D, Wasserman BA, Bonati LH, Wintermark M. Imaging biomarkers of vulnerable carotid plaques for stroke risk prediction and their potential clinical implications. Lancet Neurol. 2019;18:559\u201372.","journal-title":"Lancet Neurol"},{"key":"2939_CR7","doi-asserted-by":"crossref","unstructured":"Stefanadis C, Antoniou CK, Tsiachris D, Pietri P. Coronary atherosclerotic vulnerable plaque: current perspectives. J Am Heart Assoc 2017, 6.","DOI":"10.1161\/JAHA.117.005543"},{"key":"2939_CR8","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, Krauss RM, Raal FJ, Schunkert H, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38:2459\u201372.","journal-title":"Eur Heart J"},{"key":"2939_CR9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41569-019-0265-3","volume":"17","author":"T Kuznetsova","year":"2020","unstructured":"Kuznetsova T, Prange KHM, Glass CK, de Winther MPJ. Transcriptional and epigenetic regulation of macrophages in atherosclerosis. Nat Rev Cardiol. 2020;17:216\u201328.","journal-title":"Nat Rev Cardiol"},{"key":"2939_CR10","doi-asserted-by":"publisher","first-page":"15959","DOI":"10.1021\/acsnano.2c03422","volume":"16","author":"R Hu","year":"2022","unstructured":"Hu R, Dai C, Dong C, Ding L, Huang H, Chen Y, Zhang B. Living macrophage-delivered Tetrapod PdH Nanoenzyme for targeted atherosclerosis management by ROS scavenging, hydrogen anti-inflammation, and Autophagy activation. ACS Nano. 2022;16:15959\u201376.","journal-title":"ACS Nano"},{"key":"2939_CR11","doi-asserted-by":"publisher","first-page":"1039241","DOI":"10.3389\/fimmu.2022.1039241","volume":"13","author":"D Zheng","year":"2022","unstructured":"Zheng D, Liu J, Piao H, Zhu Z, Wei R, Liu K. ROS-triggered endothelial cell death mechanisms: focus on pyroptosis, parthanatos, and ferroptosis. Front Immunol. 2022;13:1039241.","journal-title":"Front Immunol"},{"key":"2939_CR12","doi-asserted-by":"crossref","unstructured":"Yang Q, Jiang H, Wang Y, Leng X, Wang Y, Tong J, Zhou Y, Mo C, Peng J, Gao H. Plaque macrophage-targeting Nanosystems with Cooperative Co\u2010Regulation of ROS and TRAF6 for stabilization of atherosclerotic plaques. Adv Funct Mater 2023, 33.","DOI":"10.1002\/adfm.202301053"},{"key":"2939_CR13","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jconrel.2022.12.041","volume":"353","author":"J Zhao","year":"2023","unstructured":"Zhao J, Ling L, Zhu W, Ying T, Yu T, Sun M, Zhu X, Du Y, Zhang L. M1\/M2 re-polarization of kaempferol biomimetic NPs in anti-inflammatory therapy of atherosclerosis. J Controlled Release. 2023;353:1068\u201383.","journal-title":"J Controlled Release"},{"key":"2939_CR14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jconrel.2022.06.053","volume":"349","author":"C Gao","year":"2022","unstructured":"Gao C, Liu C, Chen Q, Wang Y, Kwong CHT, Wang Q, Xie B, Lee SMY, Wang R. Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis. J Controlled Release. 2022;349:2\u201315.","journal-title":"J Controlled Release"},{"key":"2939_CR15","doi-asserted-by":"crossref","unstructured":"Sun W, Xu Y, Yao Y, Yue J, Wu Z, Li H, Shen G, Liao Y, Wang H, Zhou W. Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy. J Nanobiotechnol 2022, 20.","DOI":"10.1186\/s12951-022-01296-x"},{"key":"2939_CR16","doi-asserted-by":"publisher","first-page":"113203","DOI":"10.1016\/j.celrep.2023.113203","volume":"42","author":"D Menon","year":"2023","unstructured":"Menon D, Bhapkar A, Manchandia B, Charak G, Rathore S, Jha RM, Nahak A, Mondal M, Omrane M, Bhaskar AK, et al. ARL8B mediates lipid droplet contact and delivery to lysosomes for lipid remobilization. Cell Rep. 2023;42:113203.","journal-title":"Cell Rep"},{"key":"2939_CR17","doi-asserted-by":"crossref","unstructured":"Hu G, Yuan Z, Wang J. Autophagy inhibition and ferroptosis activation during atherosclerosis: Hypoxia-inducible factor 1\u03b1 inhibitor PX-478 alleviates atherosclerosis by inducing autophagy and suppressing ferroptosis in macrophages. Biomed Pharmacother 2023, 161.","DOI":"10.1016\/j.biopha.2023.114333"},{"key":"2939_CR18","doi-asserted-by":"publisher","first-page":"100037","DOI":"10.59717\/j.xinn-med.2023.100037","volume":"1","author":"H Liu","year":"2023","unstructured":"Liu H, Hu L, Zhang D, Wang X, Wang S. Stem cell niches functionalized strategies for organ regeneration and manufacturing. Innov Med. 2023;1:100037.","journal-title":"Innov Med"},{"key":"2939_CR19","doi-asserted-by":"crossref","unstructured":"Yang H, Liu C, Wu Y, Yuan M, Huang J, Xia Y, Ling Q, Hoffmann PR, Huang Z, Chen T. Atherosclerotic plaque-targeted nanotherapeutics ameliorates atherogenesis by blocking macrophage-driven inflammation. Nano Today 2022, 42.","DOI":"10.1016\/j.nantod.2021.101351"},{"key":"2939_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","volume":"19","author":"W Chen","year":"2022","unstructured":"Chen W, Schilperoort M, Cao Y, Shi J, Tabas I, Tao W. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis. Nat Rev Cardiol. 2022;19:228\u201349.","journal-title":"Nat Rev Cardiol"},{"key":"2939_CR21","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","volume":"118","author":"I Tabas","year":"2016","unstructured":"Tabas I, Bornfeldt KE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118:653\u201367.","journal-title":"Circ Res"},{"key":"2939_CR22","doi-asserted-by":"crossref","unstructured":"Xu M, Zhou Y, Ren C, Liang X, Li N. Palladium Hydride Nanopocket cubes and their H2-Therapy function in amplifying inhibition of Foam cells to attenuate atherosclerosis. Adv Funct Mater 2021, 31.","DOI":"10.1002\/adfm.202104892"},{"key":"2939_CR23","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1161\/CIRCRESAHA.119.315939","volume":"126","author":"I Tabas","year":"2020","unstructured":"Tabas I, Bornfeldt KE. Intracellular and intercellular aspects of macrophage immunometabolism in atherosclerosis. Circ Res. 2020;126:1209\u201327.","journal-title":"Circ Res"},{"key":"2939_CR24","doi-asserted-by":"crossref","unstructured":"Fang F, Xiao C, Li C, Liu X, Li S. Tuning macrophages for atherosclerosis treatment. Regenerative Biomaterials 2023, 10.","DOI":"10.1093\/rb\/rbac103"},{"key":"2939_CR25","doi-asserted-by":"publisher","first-page":"10608","DOI":"10.1021\/acsnano.2c02177","volume":"16","author":"Z Cao","year":"2022","unstructured":"Cao Z, Yuan G, Zeng L, Bai L, Liu X, Wu M, Sun R, Chen Z, Jiang Y, Gao Q, et al. Macrophage-targeted Sonodynamic\/Photothermal synergistic therapy for preventing atherosclerotic plaque progression using CuS\/TiO2 Heterostructured Nanosheets. ACS Nano. 2022;16:10608\u201322.","journal-title":"ACS Nano"},{"key":"2939_CR26","doi-asserted-by":"crossref","unstructured":"Pham LM, Kim E-C, Ou W, Phung CD, Nguyen TT, Pham TT, Poudel K, Gautam M, Nguyen HT, Jeong J-H et al. Targeting and clearance of senescent foamy macrophages and senescent endothelial cells by antibody-functionalized mesoporous silica nanoparticles for alleviating aorta atherosclerosis. Biomaterials 2021, 269.","DOI":"10.1016\/j.biomaterials.2021.120677"},{"key":"2939_CR27","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1016\/j.ymthe.2022.08.024","volume":"30","author":"I Hetherington","year":"2022","unstructured":"Hetherington I, Totary-Jain H. Mol Ther. 2022;30:3106.","journal-title":"Mol Ther"},{"key":"2939_CR28","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","volume":"401","author":"PM Ridker","year":"2023","unstructured":"Ridker PM, Bhatt DL, Pradhan AD, Glynn RJ, MacFadyen JG, Nissen SE. Lancet. 2023;401:1293.","journal-title":"Lancet"},{"key":"2939_CR29","doi-asserted-by":"publisher","first-page":"e2304294","DOI":"10.1002\/advs.202304294","volume":"10","author":"J Cheng","year":"2023","unstructured":"Cheng J, Huang H, Chen Y, Wu R. Nanomedicine for diagnosis and treatment of atherosclerosis. Adv Sci (Weinh). 2023;10:e2304294.","journal-title":"Adv Sci (Weinh)"},{"key":"2939_CR30","doi-asserted-by":"publisher","first-page":"e2000336","DOI":"10.1002\/adhm.202000336","volume":"9","author":"B Hu","year":"2020","unstructured":"Hu B, Boakye-Yiadom KO, Yu W, Yuan ZW, Ho W, Xu X, Zhang XQ. Nanomedicine Approaches for Advanced Diagnosis and Treatment of Atherosclerosis and related ischemic diseases. Adv Healthc Mater. 2020;9:e2000336.","journal-title":"Adv Healthc Mater"},{"key":"2939_CR31","doi-asserted-by":"crossref","unstructured":"Abideen ZU, Pathak DR, Sabanci R, Manu M, Abela GS. The effect of colchicine on cholesterol crystal formation, expansion and morphology: a potential mechanism in atherosclerosis. Front Cardiovasc Med 2024, 11.","DOI":"10.3389\/fcvm.2024.1345521"},{"key":"2939_CR32","doi-asserted-by":"crossref","unstructured":"Tang J, Li T, Xiong X, Yang Q, Su Z, Zheng M, Chen Q. Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-\u03baB\/NLRP3 pathways in inflammatory endothelial cells. J Nanobiotechnol 2023, 21.","DOI":"10.1186\/s12951-023-02228-z"},{"key":"2939_CR33","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1042\/CS20160090","volume":"130","author":"S Robertson","year":"2016","unstructured":"Robertson S, Mart\u00ednez GJ, Payet CA, Barraclough JY, Celermajer DS, Bursill C, Patel S. Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation. Clin Sci (Lond). 2016;130:1237\u201346.","journal-title":"Clin Sci (Lond)"},{"key":"2939_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/1755-5922.12226","volume":"35","author":"N Papageorgiou","year":"2017","unstructured":"Papageorgiou N, Briasoulis A, Lazaros G, Imazio M, Tousoulis D. Colchicine for prevention and treatment of cardiac diseases: a meta-analysis. Cardiovasc Ther. 2017;35:10\u20138.","journal-title":"Cardiovasc Ther"},{"key":"2939_CR35","doi-asserted-by":"crossref","unstructured":"Li Y, Che J, Chang L, Guo M, Bao X, Mu D, Sun X, Zhang X, Lu W, Xie J. CD47- and integrin \u03b14\/\u03b21\u2010Comodified\u2010macrophage\u2010membrane\u2010coated nanoparticles enable delivery of colchicine to atherosclerotic plaque. Adv Healthc Mater 2021, 11.","DOI":"10.1002\/adhm.202101788"},{"key":"2939_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41569-021-00589-2","volume":"19","author":"DM Fernandez","year":"2022","unstructured":"Fernandez DM, Giannarelli C. Immune cell profiling in atherosclerosis: role in research and precision medicine. Nat Rev Cardiol. 2022;19:43\u201358.","journal-title":"Nat Rev Cardiol"},{"key":"2939_CR37","doi-asserted-by":"crossref","unstructured":"Wen Y, Chen L, Zhou L, Leng F, Yang Z, Yu C. Bionic receptor for atherosclerosis therapy: molecularly imprinted polymers mediate unique cholesterol efflux and inhibit inflammation. Chem Eng J 2022, 430.","DOI":"10.1016\/j.cej.2021.132870"},{"key":"2939_CR38","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1021\/acsami.2c16458","volume":"15","author":"M Jia","year":"2022","unstructured":"Jia M, Ren W, Liu Y, Wang C, Zheng X, Zhang D, Tan X, Li C. Messenger Nanozyme for Reprogramming the Microenvironment of Rheumatoid Arthritis. ACS Appl Mater Interfaces. 2022;15:338\u201353.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2939_CR39","doi-asserted-by":"publisher","first-page":"14555","DOI":"10.1021\/acsnano.3c01420","volume":"17","author":"H He","year":"2023","unstructured":"He H, Han Q, Wang S, Long M, Zhang M, Li Y, Zhang Y, Gu N. Design of a multifunctional nanozyme for resolving the Proinflammatory Plaque Microenvironment and attenuating atherosclerosis. ACS Nano. 2023;17:14555\u201371.","journal-title":"ACS Nano"},{"key":"2939_CR40","doi-asserted-by":"publisher","first-page":"e2201399","DOI":"10.1002\/adhm.202201399","volume":"11","author":"J Wang","year":"2022","unstructured":"Wang J, Zhang W, Xie Z, Wang X, Luo Y, Jiang W, Liu Y, Wang Z, Ran H, Song W, Guo D. Magnetic nanodroplets for Enhanced Deep Penetration of Solid Tumors and simultaneous magnetothermal-sensitized immunotherapy against Tumor Proliferation and Metastasis. Adv Healthc Mater. 2022;11:e2201399.","journal-title":"Adv Healthc Mater"},{"key":"2939_CR41","first-page":"120","volume":"16","author":"J Hou","year":"2022","unstructured":"Hou J, Zhou J, Chang M, Bao G, Xu J, Ye M, Zhong Y, Liu S, Wang J, Zhang W, et al. LIFU-responsive nanomedicine enables acoustic droplet vaporization-induced apoptosis of macrophages for stabilizing vulnerable atherosclerotic plaques. Bioact Mater. 2022;16:120\u201333.","journal-title":"Bioact Mater"},{"key":"2939_CR42","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.59717\/j.xinn-med.2023.100015","volume":"1","author":"H Lu","year":"2023","unstructured":"Lu H, Wang Y, Yu R. Immune cell membrane-coated nanoparticles for targeted myocardial ischemia\/reperfusion injury therapy. Innov Med. 2023;1:100015.","journal-title":"Innov Med"},{"key":"2939_CR43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jconrel.2023.01.020","volume":"354","author":"Q Wang","year":"2023","unstructured":"Wang Q, Duan Y, Jing H, Wu Z, Tian Y, Gong K, Guo Q, Zhang J, Sun Y, Li Z, Duan Y. Inhibition of atherosclerosis progression by modular micelles. J Control Release. 2023;354:294\u2013304.","journal-title":"J Control Release"},{"key":"2939_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.analchem.3c03999","volume":"96","author":"Y Gu","year":"2023","unstructured":"Gu Y, Cui M, Wang W, Zhang J, Wang H, Zheng C, Lei L, Ji M, Chen W, Xu Y, Wang P. Visualization of the ferroptosis in atherosclerotic plaques with Nanoprobe Engineered by Macrophage Cell membranes. Anal Chem. 2023;96:281\u201391.","journal-title":"Anal Chem"},{"key":"2939_CR45","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/cnma.202000246","volume":"6","author":"Y Bai","year":"2020","unstructured":"Bai Y, Yao X, Wang X, Yin Y. Surface-initiated Redox Route to Hollow MnO2 nanostructures. ChemNanoMat. 2020;6:1186\u201390.","journal-title":"ChemNanoMat"},{"key":"2939_CR46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1186\/s12951-023-02228-z","volume":"21","author":"J Tang","year":"2023","unstructured":"Tang J, Li T, Xiong X, Yang Q, Su Z, Zheng M, Chen Q. Colchicine delivered by a novel nanoparticle platform alleviates atherosclerosis by targeted inhibition of NF-\u03baB\/NLRP3 pathways in inflammatory endothelial cells. J Nanobiotechnol. 2023;21:460.","journal-title":"J Nanobiotechnol"},{"key":"2939_CR47","doi-asserted-by":"publisher","first-page":"e2101788","DOI":"10.1002\/adhm.202101788","volume":"11","author":"Y Li","year":"2022","unstructured":"Li Y, Che J, Chang L, Guo M, Bao X, Mu D, Sun X, Zhang X, Lu W, Xie J. CD47- and integrin \u03b14\/\u03b21-Comodified-macrophage-membrane-coated nanoparticles enable delivery of colchicine to atherosclerotic plaque. Adv Healthc Mater. 2022;11:e2101788.","journal-title":"Adv Healthc Mater"},{"key":"2939_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1208\/s12249-020-01847-1","volume":"21","author":"L Shu","year":"2020","unstructured":"Shu L, Fu F, Huang Z, Huang Y, Hu P, Pan X. AAPS PharmSciTech. 2020;21:321.","journal-title":"AAPS PharmSciTech"},{"key":"2939_CR49","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bioactmat.2022.03.041","volume":"19","author":"J He","year":"2023","unstructured":"He J, Zhang W, Zhou X, Xu F, Zou J, Zhang Q, Zhao Y, He H, Yang H, Liu J. Bioactive Mater. 2023;19:115.","journal-title":"Bioactive Mater"},{"key":"2939_CR50","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.msec.2016.09.016","volume":"70","author":"V Forest","year":"2017","unstructured":"Forest V, Pourchez J. Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: a too simplistic explanation that does not take into account the nanoparticle protein corona. Mater Sci Eng C Mater Biol Appl. 2017;70:889\u201396.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2939_CR51","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.scitotenv.2019.05.218","volume":"682","author":"G Zhou","year":"2019","unstructured":"Zhou G, Wang Y, Zhou R, Wang C, Jin Y, Qiu J, Hua C, Cao Y. Synthesis of amino-functionalized bentonite\/CoFe(2)O(4)@MnO(2) magnetic recoverable nanoparticles for aqueous cd(2+) removal. Sci Total Environ. 2019;682:505\u201313.","journal-title":"Sci Total Environ"},{"key":"2939_CR52","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1021\/bc8003777","volume":"20","author":"Y Wei","year":"2009","unstructured":"Wei Y, Jana NR, Tan SJ, Ying JY. Surface coating directed cellular delivery of TAT-functionalized quantum dots. Bioconjug Chem. 2009;20:1752\u20138.","journal-title":"Bioconjug Chem"},{"key":"2939_CR53","doi-asserted-by":"publisher","first-page":"10414","DOI":"10.1021\/acsami.2c20492","volume":"15","author":"Y Gao","year":"2023","unstructured":"Gao Y, Liu S, Zeng X, Guo Z, Chen D, Li S, Tian Z, Qu Y. Reduction of reactive oxygen species Accumulation using Gadolinium-Doped Ceria for the alleviation of atherosclerosis. ACS Appl Mater Interfaces. 2023;15:10414\u201325.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2939_CR54","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bioactmat.2022.03.041","volume":"19","author":"J He","year":"2023","unstructured":"He J, Zhang W, Zhou X, Xu F, Zou J, Zhang Q, Zhao Y, He H, Yang H, Liu J. Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery. Bioactive Mater. 2023;19:115\u201326.","journal-title":"Bioactive Mater"},{"key":"2939_CR55","doi-asserted-by":"publisher","first-page":"25080","DOI":"10.1021\/acsami.2c02354","volume":"14","author":"R Zhao","year":"2022","unstructured":"Zhao R, Ning X, Wang M, Wang H, Xing G, Wang L, Lu C, Yu A, Wang Y. A ROS-Responsive simvastatin Nano-Prodrug and its fibronectin-targeted Co-delivery System for Atherosclerosis Treatment. ACS Appl Mater Interfaces. 2022;14:25080\u201392.","journal-title":"ACS Appl Mater Interfaces"},{"key":"2939_CR56","doi-asserted-by":"crossref","unstructured":"Xu H, She P, Ma B, Zhao Z, Li G, Wang Y. ROS responsive nanoparticles loaded with lipid-specific AIEgen for atherosclerosis-targeted diagnosis and bifunctional therapy. Biomaterials 2022, 288.","DOI":"10.1016\/j.biomaterials.2022.121734"},{"key":"2939_CR57","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.jconrel.2021.12.021","volume":"341","author":"H Zhou","year":"2022","unstructured":"Zhou H, You P, Liu H, Fan J, Tong C, Yang A, Jiang Y, Liu B. Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux. J Controlled Release. 2022;341:828\u201343.","journal-title":"J Controlled Release"},{"key":"2939_CR58","doi-asserted-by":"publisher","first-page":"114709","DOI":"10.1016\/j.addr.2023.114709","volume":"194","author":"X Zhang","year":"2023","unstructured":"Zhang X, Centurion F, Misra A, Patel S, Gu Z. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment. Adv Drug Deliv Rev. 2023;194:114709.","journal-title":"Adv Drug Deliv Rev"},{"key":"2939_CR59","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.cmet.2011.03.023","volume":"13","author":"M Ouimet","year":"2011","unstructured":"Ouimet M, Franklin V, Mak E, Liao X, Tabas I, Marcel YL. Autophagy regulates cholesterol efflux from macrophage foam cells via lysosomal acid lipase. Cell Metab. 2011;13:655\u201367.","journal-title":"Cell Metab"},{"key":"2939_CR60","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/ATVBAHA.111.240705","volume":"32","author":"M Ouimet","year":"2012","unstructured":"Ouimet M, Marcel YL. Regulation of lipid droplet cholesterol efflux from macrophage foam cells. Arterioscler Thromb Vasc Biol. 2012;32:575\u201381.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2939_CR61","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.canlet.2005.12.010","volume":"244","author":"Z Ji","year":"2006","unstructured":"Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, Peng Q. Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett. 2006;244:182\u20139.","journal-title":"Cancer Lett"},{"key":"2939_CR62","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1016\/j.atherosclerosis.2007.05.026","volume":"195","author":"A Vink","year":"2007","unstructured":"Vink A, Schoneveld AH, Lamers D, Houben AJ, van der Groep P, van Diest PJ, Pasterkamp G. HIF-1 alpha expression is associated with an atheromatous inflammatory plaque phenotype and upregulated in activated macrophages. Atherosclerosis. 2007;195:e69\u201375.","journal-title":"Atherosclerosis"},{"key":"2939_CR63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/15563650.2010.495348","volume":"48","author":"Y Finkelstein","year":"2010","unstructured":"Finkelstein Y, Aks SE, Hutson JR, Juurlink DN, Nguyen P, Dubnov-Raz G, Pollak U, Koren G, Bentur Y. Colchicine poisoning: the dark side of an ancient drug. Clin Toxicol. 2010;48:407\u201314.","journal-title":"Clin Toxicol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-02939-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-02939-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T15:06:37Z","timestamp":1730127997000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-02939-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,28]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2939"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-02939-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,28]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal experiments in this study were approved by the Animal Care and Use Committee of Chongqing Medical University and in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have approved the manuscript to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"664"}}